John Duguid is Senior Director, Research & Development at Vericel Corporation in Cambridge, MA. As a Principal Scientist, Mr. Duguid was responsible for developing, validating, and transferring molecular biology assays for rapid microbiology and cell differentiation applications, managing complex projects to implement process changes, and using statistical process control tools to implement process analytical technology for cell therapy products.
Before taking on his current role in R&D, Mr. Duguid managed quality control cell therapy operations for over 10 years. He participated as a subject matter expert during FDA inspections and audits from international regulatory authorities for material inspection and release, biopsy accessioning, endotoxin testing, mycoplasma testing, analytical methods, flow cytometry, laboratory failure investigations, assay validation, and data management.
Mr. Duguid received his Bachelor of Science degree in chemistry in 1986 from the University of Michigan in Ann Arbor. Previously, he worked in analytical research at Abbott Laboratories and then as a scientific consultant for Massachusetts biotechnology companies at Arthur D. Little. Involved with the pharmaceutical and biotechnology industries for over 20 years, Mr. Duguid has technical and management experience spanning all phases of the product lifecycle from early research and development through cGMP commercial operations.